Teneligliptin Hydrobromide 20 mg PCD Pharma Franchise

Brand Name

TNBEST-20 Tablet

Composition

Teneligliptin Hydrobromide 20mg

Therapeutic Use

ANTIDIABETICS

Size

10 x 10

Verified Exporter

Verified Seller

Trusted Pharma

Description

TNBEST-20 Tablet contains Teneligliptin Hydrobromide 20 mg, an oral antidiabetic medicine belonging to the dipeptidyl peptidase-4 (DPP-4) inhibitor class. Teneligliptin is used to help improve blood glucose control in adults with type 2 diabetes mellitus when prescribed by a qualified healthcare professional, alongside dietary management and physical activity.

Teneligliptin works by prolonging the activity of incretin hormones, which help regulate glucose-dependent insulin secretion and glucagon release. Its use should be individualized according to the patient’s blood glucose levels, medical history, other medicines and the approved prescribing information.

CardianCare is associated with cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical business partners. Businesses searching for a Teneligliptin 20 mg Tablets manufacturer India can enquire about product availability, approved specifications, manufacturing details and applicable quality documentation.

For pharmaceutical procurement teams evaluating a Teneligliptin 20 mg Tablets manufacturer and supplier India, important considerations include composition accuracy, product authorisation, packaging specifications, batch traceability, shelf life and commercial supply terms.

2. Key Ingredient

Composition:

Teneligliptin Hydrobromide 20 mg

Teneligliptin is an oral antidiabetic agent in the DPP-4 inhibitor class. It inhibits the DPP-4 enzyme, which breaks down incretin hormones such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

By prolonging incretin activity, teneligliptin helps support glucose-dependent insulin secretion and regulate glucagon secretion when blood glucose levels are elevated. This mechanism supports glycaemic management in eligible adults with type 2 diabetes.

Businesses researching a Teneligliptin 20 mg pharmaceutical company India should assess the active ingredient, approved product specifications, regulatory status, manufacturing source and applicable quality documentation.

Companies seeking a Teneligliptin 20 mg medicine manufacturer India should verify the authorised manufacturing facility, product registration, batch-specific quality records and relevant regulatory requirements before procurement.

3. Key Benefits

Blood glucose management: Helps improve glycaemic control in adults with type 2 diabetes when prescribed appropriately.

DPP-4 inhibition: Prolongs incretin hormone activity involved in glucose regulation.

Glucose-dependent action: Supports insulin secretion in response to elevated blood glucose.

Glucagon regulation: Helps regulate glucagon secretion, which contributes to blood glucose control.

Oral dosage form: Provides a Tablet-based treatment option for eligible patients.

Individualised diabetes care: May be prescribed alone or alongside selected antidiabetic medicines when clinically appropriate.

The clinical response varies between patients. Medication should be combined with appropriate dietary measures, physical activity and regular blood glucose monitoring as advised by the healthcare professional.

Pharmaceutical buyers searching for a Teneligliptin 20 mg supplier India should verify product authenticity, availability, approved packaging, shelf life and supply continuity.

A Teneligliptin 20 mg Tablet wholesaler and distributor India enquiry may include stock availability, minimum order quantities, distribution eligibility, delivery coverage and applicable commercial terms.

Businesses seeking a Teneligliptin 20 mg bulk supplier India should request a formal quotation and confirm batch traceability, storage requirements, packaging specifications and quality documentation.

A Teneligliptin 20 mg pharmaceutical distributor India should verify applicable licensing requirements, product availability and approved promotional information before beginning commercial activities.

4. How Does It Work?

Teneligliptin inhibits the DPP-4 enzyme, which normally breaks down incretin hormones such as GLP-1 and GIP. By slowing their breakdown, it prolongs the activity of these hormones.

This helps support glucose-dependent insulin secretion and regulate glucagon secretion when blood glucose levels are elevated. Together, these actions contribute to improved blood glucose regulation in adults with type 2 diabetes.

When used alone, DPP-4 inhibitors generally have a low risk of hypoglycaemia compared with medicines that directly stimulate insulin secretion. However, the risk may increase when teneligliptin is combined with insulin or sulfonylureas.

5. Directions for Use

Dosage: Take only as prescribed by a qualified doctor. The appropriate regimen depends on the patient’s condition and the approved product information.

Administration: Follow the product label and the prescriber’s instructions regarding how and when to take the Tablet.

Regular timing: Follow the prescribed schedule consistently. Do not change the dose without medical advice.

Kidney function: Tell the doctor about any kidney disease. The suitability and dosing of treatment should follow the applicable prescribing information.

Liver function: Inform the doctor about liver disease or a history of abnormal liver function.

Combination therapy: If used with insulin or sulfonylureas, the prescriber may need to review the treatment regimen because of hypoglycaemia risk.

Missed dose: Follow the patient information leaflet or ask a pharmacist or doctor for advice. Do not take a double dose to make up for a missed dose.

Monitoring: Continue recommended blood glucose monitoring, dietary measures, physical activity and follow-up appointments.

Do not start, stop or change treatment without professional medical advice.

6. Possible Side Effects

Possible side effects associated with teneligliptin may include:

Hypoglycaemia, particularly when combined with other glucose-lowering medicines

Nausea or other gastrointestinal discomfort

Constipation

Headache

Dizziness

Important but less common adverse reactions may include:

Pancreatitis: Severe, persistent abdominal pain, particularly if it spreads to the back, requires urgent medical assessment.

Allergic reactions: Swelling of the face or throat, breathing difficulty or a severe rash requires emergency care.

Skin reactions: Blistering or a severe rash should be assessed promptly by a healthcare professional.

Liver-related concerns: Unusual fatigue, dark urine or yellowing of the skin or eyes requires prompt medical evaluation.

This list is not exhaustive, and not every patient experiences side effects. Consult the approved product information and seek medical advice about any persistent or concerning symptoms.

7. Safety Information

Medical supervision: Use only under the guidance of a qualified healthcare professional.

Contraindications: Do not use if there is a known serious allergy to teneligliptin or any ingredient in the formulation.

Kidney health: Inform the prescriber about kidney impairment so treatment suitability can be assessed according to the approved label.

Liver health: Discuss existing liver disease and follow any recommended liver function monitoring.

Pancreatic health: Tell the doctor about a history of pancreatitis. Seek urgent care if symptoms suggest acute pancreatitis.

Hypoglycaemia: Risk may increase when used with insulin or sulfonylureas. Follow medical advice about recognising and managing low blood glucose.

Pregnancy and breastfeeding: Consult a doctor before use during pregnancy, when planning pregnancy or while breastfeeding. The clinician should assess the most appropriate treatment.

Drug interactions: Inform the doctor about all prescription medicines, over-the-counter products and supplements.

Storage: Store in the original packaging according to the approved product label, protected from excessive heat and moisture and out of reach of children.

Driving and machinery: If dizziness or low blood glucose occurs, avoid driving or operating machinery until it is safe to do so.

This information is educational and does not replace approved prescribing information or individual medical advice.

8. B2B Pharmaceutical Business Enquiries

CardianCare is associated with cardiac and diabetic healthcare products for healthcare professionals and pharmaceutical trade partners. Distributors, wholesalers, pharmacists and eligible business partners should confirm current product availability, approved specifications and commercial arrangements directly with the company.

Businesses researching a Teneligliptin Hydrobromide 20 mg PCD pharma franchise India opportunity can enquire about product availability, partner eligibility, territory terms and applicable business requirements.

For a Teneligliptin Hydrobromide 20 mg Tablets PCD pharma franchise enquiry, prospective partners can request information about current product listings, minimum order requirements, distribution eligibility and any promotional support that may be available.

Companies exploring a Teneligliptin Hydrobromide 20 mg Tablet PCD franchise should confirm whether the product is included in a current programme before making investment or promotional commitments.

Businesses evaluating Teneligliptin Hydrobromide 20 mg third party manufacturing India services should first confirm whether the proposed company offers such arrangements. Relevant checks include manufacturing permissions, product authorisation, applicable GMP compliance, minimum batch quantities and quality documentation.

A Teneligliptin Hydrobromide 20 mg Tablet third party manufacturer India enquiry should cover the authorised manufacturing facility, quality systems, batch release procedures, packaging specifications and regulatory responsibilities.

Companies researching Teneligliptin Hydrobromide 20 mg contract manufacturing India should confirm service availability directly with the proposed manufacturing partner and review formulation specifications, technical documentation, quality agreements, regulatory responsibilities and commercial feasibility.

Contact CardianCare through its official website to enquire about current product availability and eligible pharmaceutical business opportunities. Distribution, franchise and manufacturing services must be confirmed directly with the company before being advertised as available.

For more information about TNBEST-20 Tablet (Teneligliptin Hydrobromide 20 mg), click here

Frequently Asked Questions

Teneligliptin is an oral antidiabetic medicine used to help improve blood glucose control in adults with type 2 diabetes mellitus when prescribed by a healthcare professional, alongside diet and exercise.

The supplied composition is Teneligliptin Hydrobromide 20 mg. Verify the exact salt expression and strength against the approved product label before publishing product specifications.

Teneligliptin inhibits the DPP-4 enzyme, prolonging incretin hormone activity and supporting glucose-dependent insulin secretion and glucagon regulation.

It offers an oral treatment option that can help improve glycaemic control in eligible adults with type 2 diabetes. Individual results depend on the patient's clinical condition and overall treatment plan.

Take it according to the doctor's instructions and the approved product label. Follow the prescribed schedule and do not change the dose independently.

Possible effects include hypoglycaemia, gastrointestinal discomfort, constipation, headache or dizziness. Severe abdominal pain or a serious allergic reaction requires urgent medical attention.

People with a history of pancreatitis, kidney or liver disease, significant allergies, pregnancy or breastfeeding considerations, or other major medical conditions should discuss suitability with their healthcare professional.

It may be prescribed with selected antidiabetic medicines when clinically appropriate. The risk of hypoglycaemia can increase when combined with insulin or sulfonylureas, so medical monitoring is important.

Buyers should verify the active ingredient, strength, approved dosage form, product authorisation, manufacturing source, applicable quality documentation, batch traceability, shelf life, packaging and commercial supply terms.

Eligible pharmaceutical businesses can contact CardianCare through its official website to enquire about current product availability and applicable distribution or franchise arrangements. Confirm all services and commercial terms directly with the company.

Reviews

There are no reviews yet.

Be the first to review “Teneligliptin Hydrobromide 20 mg PCD Pharma Franchise”

Your email address will not be published. Required fields are marked *

Enquiry Now
close slider

    Drop us a Line